Location: Home
  • search
  • go
  • Relate News
  • 1/19/2018CFDA Solicits Comments on Measures for Drug Evaluation and Approval In...
  • 1/19/2018CFDA Issues Guidance Opinions for Further Strengthening Food and Drug ...
  • 1/19/2018118 Listed Chinese Pharma Cos Report 2017 Performance Guidance
  • 1/19/2018Recent Executive Moves
  • 1/19/2018Xiangxue Pharma Ties Up with GE Unit to Produce Cancer Immunotherapy P...
  • 1/19/2018New Study: 40% of Chinese Adults Suffer from High Blood Pressure
  • 1/19/2018Chinese and American Scientists Find New Approach to Develop Flu Vacci...
  • 1/19/2018Ascletis Seeks Third Round of Funding That Could Exceed US$100M
  • 1/19/2018Made in China: New and Potentially Lifesaving Drugs
  • 1/19/2018Mundipharma to Take Over Marketing of Grunenthal's Pain-Relief Drug in...
  • 1/19/2018CFDA Approves New Indication of Mitsubishi Tanabe's Novastan
  • 1/19/2018Update on US Investigation of China's IP Practices
  • 1/19/2018USDOC Points Out "Shortcomings" in China's Pharma IP Arena
  • 1/19/2018Fosun-Backed Shanghai Henlius Biotech Eyes IPOs on Both Mainland and H...
  • 1/19/2018CITIC Capital Becomes Controlling Shareholder of Harbin Pharma
  • 1/19/2018Fear of Substandard Medicines Lead to Expanding Opportunities for US P...
  • 1/19/2018India to Blacklist Eight Chinese Pharma Companies for Quality Issues
  • 1/18/2018EMA Bans Amoxicillin API from Changsheng Pharma after Identifying Defi...
  • 1/18/2018Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clini...
  • 1/18/2018Xbrane, CR Pharma Sign Letter of Intent for Lucentis Biosimilar in Chi...
  • 1/18/2018Suven Granted A Patent in China for NCEs Targeting Neuro Disorders
  • 1/18/2018Eisai Completes Construction of OSD Production Facility in China
  • 1/18/2018New Opportunities in Emerging Markets
  • 1/17/2018Amarin Announces Commencement of VASCEPA Clinical Development in Mainl...
  • 1/17/2018Innovent eyes IPO Later This Year, Possibly in the U.S.
  • 1/17/2018First Chronic HepB Patient Dosed in China in Transgene's Phase 1 Trial...
  • 1/17/2018China's Medical Representative Registration System: Action Items for P...
  • 1/17/20183SBio Licenses Mainland China Rights of Toray's Antipruritic Agent TRK...
  • 1/16/2018Clinical Trials Registered on the CDE Platform Rebound to a New Peak i...
  • 1/16/2018Data Snapshot: Overseas Out-licensing Deals of Novel Drugs Developed i...
  • Page:351/789 Total number of articles:23668: [First][<<] [349] [350] [351] [352] [353] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group